Allogene Therapeutics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 06/17/2022   Download
SEC Document
SEC Filing
The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Authorized Shares Amendment”) to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000.